Molecular imaging of fibroblast activation in systemic sclerosis using [18F]AlF-NOTA-FAPI-04 PET/CT: a prospective cohort study
European Journal of Nuclear Medicine and Molecular Imaging · 2026-04 · 53 (5) · 3422-3436
DOI: 10.1007/s00259-025-07586-4 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 06.12.2025. Verfasst von Meixin Zhao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Peking University Third Hospital, 49 North Garden Road, Haidian District, Beijing, 100191, P. R. China. Hauptthemen laut MEDLINE: Scleroderma, Systemic, Positron Emission Tomography Computed Tomography, Fibroblasts, Molecular Imaging. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Key Clinical Projects of Peking University Third Hospital, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Peking University Third Hospital, 49 North Garden Road, Haidian District, Beijing, 100191, P. R. China.
- Department of Rheumatology and Immunology, Peking University Third Hospital, 49 North Garden Road, Haidian District, Beijing, 100191, P. R. China.
- Department of Biomedical Imaging and Image-guided Therapy, Division of Nuclear Medicine, Vienna General Hospital, Medical University of Vienna, Vienna, Währinger Gürtel 18- 20, 1090, Austria.
- Department of Nuclear Medicine, Peking University Third Hospital, 49 North Garden Road, Haidian District, Beijing, 100191, P. R. China. tsy1997@126.com.
- Department of Rheumatology and Immunology, Peking University Third Hospital, 49 North Garden Road, Haidian District, Beijing, 100191, P. R. China. murongster@163.com.
- Department of Nuclear Medicine, Beijing Chest Hospital, Capital Medical University, Beijing, China.
ORCID-Profile: Weifang Zhang
Förderung
- Key Clinical Projects of Peking University Third Hospital
- National Natural Science Foundation of China
Zitieren
APA
Zhao, M., Wei, H., Wang, M., Wang, Z., Li, X., Li, H., Zhang, A., Xue, S., Hacker, M., Zhang, W., Mu, R., & Li, X. (2026). Molecular imaging of fibroblast activation in systemic sclerosis using [18F]AlF-NOTA-FAPI-04 PET/CT: a prospective cohort study. European Journal of Nuclear Medicine and Molecular Imaging, 53(5), 3422-3436. https://doi.org/10.1007/s00259-025-07586-4
Vancouver
Zhao M, Wei H, Wang M, Wang Z, Li X, Li H, et al. Molecular imaging of fibroblast activation in systemic sclerosis using [18F]AlF-NOTA-FAPI-04 PET/CT: a prospective cohort study. European Journal of Nuclear Medicine and Molecular Imaging. 2026;53(5):3422-3436. doi:10.1007/s00259-025-07586-4
BibTeX
@article{Zhao2026,
author = {Zhao, Meixin and Wei, Hui and Wang, Meng and Wang, Zeyang and Li, Xinwei and Li, Hui and Zhang, Annan and Xue, Song and Hacker, Marcus and Zhang, Weifang and Mu, Rong and Li, Xiang},
title = {Molecular imaging of fibroblast activation in systemic sclerosis using [18F]AlF-NOTA-FAPI-04 PET/CT: a prospective cohort study},
journal = {European Journal of Nuclear Medicine and Molecular Imaging},
year = {2026},
volume = {53},
number = {5},
pages = {3422--3436},
doi = {10.1007/s00259-025-07586-4}
}
EUVIMED